當前位置：首頁 SCI期刊 SCIE期刊醫學中科院3區 JCRQ1 期刊介紹(非官網)

Journal Of Infection And Public HealthSCIE

國際簡稱：J INFECT PUBLIC HEAL 參考譯名：感染與公共衛生雜志

中科院分區
3區
CiteScore分區
Q1
JCR分區
Q1

基本信息：: ISSN：1876-0341; E-ISSN：1876-035X; 是否OA：開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：ENGLAND; 出版商：Elsevier BV; 出版語言：English; 出版周期：4 issues/year; 出版年份：2008; 研究方向：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH?-INFECTIOUS DISEASES

評價信息：: 影響因子：4.7; H-index：25; CiteScore指數：13.1; SJR指數：1.081; SNIP指數：1.225

發文數據：: Gold OA文章占比：95.65%; 研究類文章占比：84.69%; 年發文量：294; 自引率：0.0149...; 開源占比：0.9604; 出版撤稿占比：0; 出版國人文章占比：0.12; OA被引用占比：1

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Journal Of Infection And Public Health期刊介紹

The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.

The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.

It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.

期刊簡介Journal Of Infection And Public Health期刊介紹

《Journal Of Infection And Public Health》自2008出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間： 49 Weeks
醫學
INFECTIOUS DISEASES
SCIE
中科院3區
非預警

Cite Score數據（2024年最新版）Journal Of Infection And Public Health Cite Score數據

CiteScore：13.1
SJR：1.081
SNIP：1.225

學科類別	分區	排名	百分位
大類：Medicine 小類：Public Health, Environmental and Occupational Health	Q1	22 / 665	96%
大類：Medicine 小類：Infectious Diseases	Q1	31 / 344	91%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Journal Of Infection And Public Health 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	3區	INFECTIOUS DISEASES 傳染病學 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共衛生、環境衛生與職業衛生	3區 3區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Journal Of Infection And Public Health JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：INFECTIOUS DISEASES	SCIE	Q1	20 / 132	85.2%
學科：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH	SCIE	Q1	40 / 403	90.2%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：INFECTIOUS DISEASES	SCIE	Q1	19 / 132	85.98%
學科：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH	SCIE	Q1	45 / 403	88.96%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
Saudi Arabia151
CHINA MAINLAND116
India79
USA66
Egypt42
Pakistan37
Italy30
Brazil25
Lebanon25
Turkey25

本刊中國學者近年發表論文

1、Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: A cross-sectional survey
Author: Wang, Bingyi; Peng, Xin; Li, Yuwei; Fu, Leiwen; Tian, Tian; Liang, Bingyu; Sun, Yinghui; Chen, Yuanyi; Wu, Xinsheng; Liu, Qi; Lin, Yi-Fan; Meng, Xiaojun; Zou, Huachun

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 2, pp. 163-170. DOI: 10.1016/j.jiph.2022.12.010
2、Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China
Author: Shen, Xiaolei; Wang, Ping; Shen, Jun; Jiang, Yuhan; Wu, Li; Nie, Xin; Liu, Jianren; Chen, Wei

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 2, pp. 155-162. DOI: 10.1016/j.jiph.2022.12.005
3、Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Author: Dhama, Kuldeep; Nainu, Firzan; Frediansyah, Andri; Yatoo, Mohd Iqbal; Mohapatra, Ranjan K.; Chakraborty, Sandip; Zhou, Hao; Islam, Md. Rabiul; Mamada, Sukamto S.; Kusuma, Hendrix Indra; Rabaan, Ali A.; Alhumaid, Saad; Al Mutair, Abbas; Iqhrammullah, Muhammad; Al-Tawfiq, Jaffar A.; Al Mohaini, Mohammed; Alsalman, Abdulkhaliq J.; Tuli, Hardeep Singh; Chakraborty, Chiranjib; Harapan, Harapan

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 1, pp. 4-14. DOI: 10.1016/j.jiph.2022.11.024
4、Brucella cultures characteristics, clinical characteristics, and infection biomarkers of human Brucellosis
Author: Feng, Qiangsheng; Ha, Xiaoqin; Lin, Tong; Guo, Wenyun; Song, Yuejuan

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 303-309. DOI: 10.1016/j.jiph.2023.01.002
5、Perceptions and worries about monkeypox, and attitudes towards monkeypox vaccination among medical workers in China: A cross-sectional survey
Author: Peng, Xin; Wang, Bingyi; Li, Yuwei; Chen, Yuanyi; Wu, Xinsheng; Fu, Leiwen; Sun, Yinghui; Liu, Qi; Lin, Yi-Fan; Liang, Bingyu; Fan, Yinguang; Zou, Huachun

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 346-353. DOI: 10.1016/j.jiph.2023.01.010
6、Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in China
Author: Shi, Xiaoping; Fu, Jie; Li, Xiaoyu; Lv, Qianzhou; Wan, Xu; Xu, Qing

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 361-367. DOI: 10.1016/j.jiph.2023.01.008
7、Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China
Author: Su, Yang; Xing, Huan; Shen, Weijun; Li, Ming; Xu, Yawei; Li, Yingchuan

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 418-421. DOI: 10.1016/j.jiph.2023.01.003
8、Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China
Author: Sha, Jichao; Meng, Cuida; Sun, Jing; Sun, Liwei; Gu, Rui; Liu, Junzhi; Zhu, Xuewei; Zhu, Dongdong

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 422-429. DOI: 10.1016/j.jiph.2023.01.013